Skip to main content

Table 1 Mendelian randomization results and heterogeneity analysis for effect of genetically predicted fatty acid metabolites on asthma

From: Association between circulating fatty acid metabolites and asthma risk: a two-sample bidirectional Mendelian randomization study

Method

No. of SNPs

MR analysis

Heterogeneity test

MR-Egger intercept P

OR (95% CI)

P

Cochran’s Q

I2

P

Ratio of bis-allylic groups to double bonds

IVW

35

1.05 (1.03–1.08)

2.09 × 10–4

47.24

28.03%

0.07

 

Weighted Median

35

1.10 (1.06–1.14)

1.67 × 10–7

–

–

–

 

MR-Egger

35

1.09 (1.04–1.14)

5.75 × 10–4

42.81

22.91%

0.12

0.07

Ratio of bis-allylic groups to total fatty acids

IVW

34

1.06 (1.03–1.10)

3.3 × 10–4

71.54

53.87%

8.11 × 10–5

 

Weighted Median

34

1.12 (1.07–1.16)

1.52 × 10–8

    

MR-Egger

34

1.07 (1.02–1.13)

1.6 × 10–2

71.28

55.11%

1.15 × 10–4

0.73

Average number of methylene groups in a fatty acid

IVW

30

0.92 (0.88–0.96)

4.69 × 10–5

47.46

38.90%

1.67 × 10–2

 

Weighted Median

30

0.93 (0.87–0.98)

1.12 × 10–2

    

MR-Egger

30

0.86 (0.81–0.93)

2.69 × 10–4

41.36

32.30%

4.97 × 10–2

0.05

  1. Results from primary two sample MR analysis, estimated associations reported as odds ratio (OR) of outcome per unit increase in log odds of the quantification of specific traits; No. of SNPs refers to the number of valid instrumental variables for each exposure included in final MR analysis
  2. MR Mendelian randomization